![Frontiers | Cochlear implant-specific risks should be considered, when assessing the quality of life of children and adolescents with hearing loss and cochlear implants–not just cochlear implant-specific benefits–Perspective Frontiers | Cochlear implant-specific risks should be considered, when assessing the quality of life of children and adolescents with hearing loss and cochlear implants–not just cochlear implant-specific benefits–Perspective](https://www.frontiersin.org/files/Articles/985230/fnins-16-985230-HTML/image_m/fnins-16-985230-g001.jpg)
Frontiers | Cochlear implant-specific risks should be considered, when assessing the quality of life of children and adolescents with hearing loss and cochlear implants–not just cochlear implant-specific benefits–Perspective
![Frontiers | Major Evolutionary Transitions and the Roles of Facilitation and Information in Ecosystem Transformations Frontiers | Major Evolutionary Transitions and the Roles of Facilitation and Information in Ecosystem Transformations](https://www.frontiersin.org/files/Articles/711556/fevo-09-711556-HTML-r2/image_m/fevo-09-711556-g001.jpg)
Frontiers | Major Evolutionary Transitions and the Roles of Facilitation and Information in Ecosystem Transformations
![Frontiers | Auricular Vagus Neuromodulation—A Systematic Review on Quality of Evidence and Clinical Effects Frontiers | Auricular Vagus Neuromodulation—A Systematic Review on Quality of Evidence and Clinical Effects](https://www.frontiersin.org/files/Articles/664740/fnins-15-664740-HTML-r1/image_m/fnins-15-664740-g001.jpg)
Frontiers | Auricular Vagus Neuromodulation—A Systematic Review on Quality of Evidence and Clinical Effects
![Clinical effectiveness of active Alpha-Stim AID versus sham Alpha-Stim AID in major depression in primary care in England (Alpha-Stim-D): a multicentre, parallel group, double-blind, randomised controlled trial - The Lancet Psychiatry Clinical effectiveness of active Alpha-Stim AID versus sham Alpha-Stim AID in major depression in primary care in England (Alpha-Stim-D): a multicentre, parallel group, double-blind, randomised controlled trial - The Lancet Psychiatry](https://www.thelancet.com/cms/asset/e7280a4b-e4e1-4970-8995-86d4ae424f2f/gr1.jpg)